| Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy A Pujol, C Hindelang, N Callizot, U Bartsch, M Schachner, JL Mandel Human molecular genetics 11 (5), 499-505, 2002 | 240 | 2002 |
| Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy A Pujol, I Ferrer, C Camps, E Metzger, C Hindelang, N Callizot, M Ruiz, ... Human molecular genetics 13 (23), 2997-3006, 2004 | 229 | 2004 |
| Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy B Beyreuther, N Callizot, T Stöhr European journal of pharmacology 539 (1-2), 64-70, 2006 | 149 | 2006 |
| Antinociceptive efficacy of lacosamide in the monosodium iodoacetate rat model for osteoarthritis pain B Beyreuther, N Callizot, T Stöhr Arthritis Research & Therapy 9, 1-8, 2007 | 105 | 2007 |
| PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons … NP Visanji, A Orsi, TH Johnston, PA Howson, K Dixon, N Callizot, ... The FASEB Journal 22 (7), 2488-2497, 2008 | 102 | 2008 |
| Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity N Callizot, E Andriambeloson, J Glass, M Revel, P Ferro, R Cirillo, ... Cancer chemotherapy and pharmacology 62, 995-1007, 2008 | 84 | 2008 |
| Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins N Callizot, M Combes, A Henriques, P Poindron PloS one 14 (4), e0215277, 2019 | 80 | 2019 |
| Mice lacking glutamate carboxypeptidase II are protected from peripheral neuropathy and ischemic brain injury DJ Bacich, KM Wozniak, XCM Lu, DS O'Keefe, N Callizot, WDW Heston, ... Journal of neurochemistry 95 (2), 314-323, 2005 | 80 | 2005 |
| Antinociceptive efficacy of lacosamide in rat models for tumor-and chemotherapy-induced cancer pain BK Beyreuther, N Callizot, MD Brot, R Feldman, SC Bain, T Stöhr European journal of pharmacology 565 (1-3), 98-104, 2007 | 74 | 2007 |
| Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy I Chumakov, S Nabirotchkin, N Cholet, A Milet, A Boucard, D Toulorge, ... Scientific reports 5 (1), 7608, 2015 | 73 | 2015 |
| Interleukin‐6 attenuates the development of experimental diabetes‐related neuropathy E Andriambeloson, C Baillet, PA Vitte, G Garotta, M Dreano, N Callizot Neuropathology 26 (1), 32-42, 2006 | 66 | 2006 |
| Ambroxol hydrochloride improves motor functions and extends survival in a mouse model of familial amyotrophic lateral sclerosis A Bouscary, C Quessada, A Mosbach, N Callizot, M Spedding, JP Loeffler, ... Frontiers in pharmacology 10, 883, 2019 | 46 | 2019 |
| Pyridoxine-induced neuropathy in rats: a sensory neuropathy that responds to 4-methylcatechol N Callizot, JM Warter, P Poindron Neurobiology of Disease 8 (4), 626-635, 2001 | 41 | 2001 |
| A new long term in vitro model of myelination N Callizot, M Combes, R Steinschneider, P Poindron Experimental cell research 317 (16), 2374-2383, 2011 | 39 | 2011 |
| Operational dissection of β‐amyloid cytopathic effects on cultured neurons N Callizot, M Combes, R Steinschneider, P Poindron Journal of Neuroscience Research 91 (5), 706-716, 2013 | 32 | 2013 |
| Huperzia serrata Extract ‘NSP01’ With Neuroprotective Effects-Potential Synergies of Huperzine A and Polyphenols N Callizot, ML Campanari, L Rouvière, G Jacquemot, A Henriques, ... Frontiers in Pharmacology 12, 681532, 2021 | 25 | 2021 |
| AZP2006, a new promising treatment for Alzheimer’s and related diseases N Callizot, C Estrella, S Burlet, A Henriques, C Brantis, M Barrier, ... Scientific reports 11 (1), 16806, 2021 | 22 | 2021 |
| Substituted α-Phenyl and α-Naphthlyl-N-tert-butyl Nitrones: Synthesis, Spin-Trapping, and Neuroprotection Evaluation A Deletraz, K Zéamari, K Hua, M Combes, FA Villamena, B Tuccio, ... The Journal of Organic Chemistry 85 (9), 6073-6085, 2020 | 21 | 2020 |
| Glutamate carboxypeptidase II inhibition behaviorally and physiologically improves pyridoxine-induced neuropathy in rats MC Potter, KM Wozniak, N Callizot, BS Slusher PloS one 9 (9), e102936, 2014 | 21 | 2014 |
| Combination of acamprosate and baclofen (PXT864) as a potential new therapy for amyotrophic lateral sclerosis L Boussicault, J Laffaire, P Schmitt, P Rinaudo, N Callizot, S Nabirotchkin, ... Journal of neuroscience research 98 (12), 2435-2450, 2020 | 19 | 2020 |